161 related articles for article (PubMed ID: 27272076)
1. Bimatoprost 0.03% Solution for the Treatment of Nonfacial Vitiligo.
Grimes PE
J Drugs Dermatol; 2016 Jun; 15(6):703-10. PubMed ID: 27272076
[TBL] [Abstract][Full Text] [Related]
2. Comparative study between efficacy of Excimer light with topical Tacrolimus 0.1% versus excimer light with topical Bimatoprost 0.01% in treatment of facial Vitiligo.
Zaky MS; Atallah RB; El Abasy NTA; Elsaie ML
Arch Dermatol Res; 2024 Jun; 316(7):350. PubMed ID: 38850408
[TBL] [Abstract][Full Text] [Related]
3. Bimatoprost ophthalmic solution in facial vitiligo.
Jha AK; Prasad S; Sinha R
J Cosmet Dermatol; 2018 Jun; 17(3):437-440. PubMed ID: 29034590
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of topical bimatoprost for nonsegmental facial vitiligo: A preliminary study.
Kanokrungsee S; Pruettivorawongse D; Rajatanavin N
J Cosmet Dermatol; 2021 Mar; 20(3):812-818. PubMed ID: 32744369
[TBL] [Abstract][Full Text] [Related]
5. Triple combination therapy of narrowband ultraviolet B, fractional carbon dioxide laser and topical bimatoprost 0.01% for non-segmental vitiligo on non-facial areas: A randomized half-body, double-blind, placebo-controlled, comparative study.
Kanokrungsee S; Khunkhet S; Rojhirunsakool S; Thadvibun K; Sahaspot T
Dermatol Ther; 2022 Jan; 35(1):e15198. PubMed ID: 34750933
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of bimatoprost ophthalmic solution combined with NB-UVB phototherapy in non-segmental and segmental vitiligo: a single-blind randomized controlled study.
Silpa-Archa N; Likittanasombat S; Apinuntham C; Pruksaeakanan C; Charoenpipatsin N; Chaiyabutr C; Wongpraparut C
Sci Rep; 2023 Apr; 13(1):6438. PubMed ID: 37081101
[TBL] [Abstract][Full Text] [Related]
7. Action of topical mometasone on the pigmented halos of micrografting in patients with vitiligo.
Saldanha KD; Machado Filho CD; Paschoal FM
An Bras Dermatol; 2012; 87(5):685-90. PubMed ID: 23044558
[TBL] [Abstract][Full Text] [Related]
8. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
Asawanonda P; Klahan SO
Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
[TBL] [Abstract][Full Text] [Related]
9. A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis.
Guenther LC; Poulin YP; Pariser DM
Clin Ther; 2000 Oct; 22(10):1225-38. PubMed ID: 11110233
[TBL] [Abstract][Full Text] [Related]
10. Microdermabrasion and topical tacrolimus: A novel combination therapy of vitiligo.
Abd-Elazim NE; Yassa HA; Mahran AM
J Cosmet Dermatol; 2020 Jun; 19(6):1447-1455. PubMed ID: 31668003
[TBL] [Abstract][Full Text] [Related]
11. Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study.
van Zyl-Smit RN; Krüll M; Gessner C; Gon Y; Noga O; Richard A; de Los Reyes A; Shu X; Pethe A; Tanase AM; D'Andrea P;
Lancet Respir Med; 2020 Oct; 8(10):987-999. PubMed ID: 32653075
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of a combined 308-nm excimer lamp and topical mid-potent steroid treatment for facial vitiligo: a preliminary, randomized double-blinded controlled study.
Juntongjin P; Toncharoenphong N
Lasers Med Sci; 2020 Dec; 35(9):2023-2029. PubMed ID: 32458080
[TBL] [Abstract][Full Text] [Related]
13. An open label study to compare the efficacy of topical mometasone furoate with topical placental extract versus topical mometasone furoate with topical tacrolimus in patients with vitiligo involving less than 10% body surface area.
Shrestha S; Jha AK; Thapa DP; Bhattarai CK; Ghimire A
Nepal Med Coll J; 2014 Sep; 16(1):1-4. PubMed ID: 25799800
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Tacrolimus 0.1% for the Treatment of Facial Vitiligo: A Multicenter Randomized, Double-Blinded, Vehicle-Controlled Study.
Seneschal J; Duplaine A; Maillard H; Passeron T; Andreu N; Lassalle R; Favary C; Droitcourt C; Taïeb A; Ezzedine K
J Invest Dermatol; 2021 Jul; 141(7):1728-1734. PubMed ID: 33549606
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.
Rodríguez-Martín M; García Bustínduy M; Sáez Rodríguez M; Noda Cabrera A
Br J Dermatol; 2009 Feb; 160(2):409-14. PubMed ID: 19016706
[TBL] [Abstract][Full Text] [Related]
16. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.
Spangler DL; Abelson MB; Ober A; Gotnes PJ
Clin Ther; 2003 Aug; 25(8):2245-67. PubMed ID: 14512132
[TBL] [Abstract][Full Text] [Related]
17. Mometasone cream versus pimecrolimus cream for the treatment of childhood localized vitiligo.
Köse O; Arca E; Kurumlu Z
J Dermatolog Treat; 2010 May; 21(3):133-9. PubMed ID: 20394489
[TBL] [Abstract][Full Text] [Related]
18. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis.
Anolik R;
Ann Allergy Asthma Immunol; 2008 Mar; 100(3):264-71. PubMed ID: 18426147
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis.
Stjärne P; Mösges R; Jorissen M; Passàli D; Bellussi L; Staudinger H; Danzig M
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):179-85. PubMed ID: 16490876
[TBL] [Abstract][Full Text] [Related]
20. A prospective right-left comparative study to evaluate the efficacy and tolerability of combination of NB-UVB and topical bimatoprost 0.03% eye drops versus NB-UVB given alone in patients of vitiligo vulgaris.
Sharma S; Parsad D; Bhattacharjee R; Muthu SK
J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):e330-e331. PubMed ID: 29444382
[No Abstract] [Full Text] [Related]
[Next] [New Search]